/Investor DB

OUP (Osage University Partners) — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Quintessentquintessent.comSeed · Oct 2023 · $12M

Quintessent develops optical connectivity solutions to address chip-to-chip communication bottlenecks in large-scale computing and AI systems.

AI & Machine LearningCloud ComputingDeep TechHardwareSemiconductorsSanta Barbara, US

Alan Liu(CEO, Co-Founder & Board Member)inBrian Koch(VP of Engineering & Co-Founder)inJohn Bowers(Chairman of the Board & Co-Founder)Robert Nunn(Executive Officer, Director)Manny Stockman(Director)Gerd Goette(Director)

Co-investorsEntrada VenturesFoothill VenturesM VenturesSierra VenturesCycle CapitalIntervest+2 more

Redonaredonatx.cominJul 2023

Redona Therapeutics is a drug discovery company co-founded by Harvard Medical School investigators focused on novel areas of biology.

AI & Machine LearningBiotechBoston, US

George Daley(Co-founder)Richard Gregory(Co-founder)Frank Slack(Co-founder)Piotr Sliz(Co-founder)inKazumi Shiosaki(President & CEO)in

BoardMichal Silverberg(Director)

Co-investorsAstellas Venture Management LLCSofinnova PartnersMPM BioImpact

TruLite Healthtrulitehealth.cominSeries A · Aug 2023 · $7M

Trulite Health offers clinical software that combines patient-specific clinical data (pulled from EHRs) and social data to surface health optimization insights, clinician recommendations, and patient education aimed at reducing bias and closing care gaps for diverse patient populations.

AI & Machine LearningDigital HealthHealthtechSaaSTempe, US

Alan C. Roga(Executive Officer, Director)inJohn Barravecchia(Executive Officer)inShaung Liu(Executive Officer)in

BoardCaleb DesRosiers(Director)

Co-investorsOsage Venture PartnersService Provider CapitalXcellerant VenturesInflect Health

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.